Ascendis Pharma | Sustainability Performance
Ascendis Pharma A/S develops therapies focused on improving patients' lives by addressing unmet medical needs. The company utilizes its proprietary technology to create innovative treatments in endocrinology and other therapeutic areas, aiming for sustained efficacy and improved patient outcomes.
2007
Denmark
501 - 1,000 employees
Biotechnology
$500M - 1B in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#7703
Overallⓘ#138
in Denmarkⓘ#169
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Digital emissions
Controversy level
Powered by illuminem
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.